Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 2
2008 1
2009 1
2012 1
2013 6
2014 7
2015 6
2016 6
2017 10
2018 7
2019 3
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Results by year
Filters applied: . Clear all
Page 1
Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
Hou GX, Liu P, Yang J, Wen S. Hou GX, et al. Among authors: wen s. PLoS One. 2017 Mar 29;12(3):e0174515. doi: 10.1371/journal.pone.0174515. eCollection 2017. PLoS One. 2017. PMID: 28355294 Free PMC article.
REV-ERBα Regulates CYP7A1 Through Repression of Liver Receptor Homolog-1.
Zhang T, Zhao M, Lu D, Wang S, Yu F, Guo L, Wen S, Wu B. Zhang T, et al. Among authors: wen s. Drug Metab Dispos. 2018 Mar;46(3):248-258. doi: 10.1124/dmd.117.078105. Epub 2017 Dec 13. Drug Metab Dispos. 2018. PMID: 29237721
Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis.
Hou GX, Liu PP, Zhang S, Yang M, Liao J, Yang J, Hu Y, Jiang WQ, Wen S, Huang P. Hou GX, et al. Among authors: wen s. Cell Death Dis. 2018 Jan 24;9(2):89. doi: 10.1038/s41419-017-0159-4. Cell Death Dis. 2018. PMID: 29367724 Free PMC article.
Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo.
Wen S, Wang J, Liu P, Li Y, Lu W, Hu Y, Liu J, He Z, Huang P. Wen S, et al. Cancer Lett. 2018 Jan 28;413:35-45. doi: 10.1016/j.canlet.2017.10.015. Epub 2017 Oct 22. Cancer Lett. 2018. PMID: 29069576
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis.
You X, Jiang W, Lu W, Zhang H, Yu T, Tian J, Wen S, Garcia-Manero G, Huang P, Hu Y. You X, et al. Among authors: wen s. Cancer Commun (Lond). 2019 Apr 4;39(1):17. doi: 10.1186/s40880-019-0362-z. Cancer Commun (Lond). 2019. PMID: 30947742 Free PMC article.
Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug.
Chen J, Luo B, Wen S, Pi R. Chen J, et al. Among authors: wen s. Invest New Drugs. 2020 Jun;38(3):755-764. doi: 10.1007/s10637-019-00821-4. Epub 2019 Aug 14. Invest New Drugs. 2020. PMID: 31414267
Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signaling.
Liao J, Liu PP, Hou G, Shao J, Yang J, Liu K, Lu W, Wen S, Hu Y, Huang P. Liao J, et al. Among authors: wen s. Mol Cancer. 2017 Feb 28;16(1):51. doi: 10.1186/s12943-017-0623-x. Mol Cancer. 2017. PMID: 28245869 Free PMC article.
Synthesis and biological evaluation of 20-epi-amino-20-deoxysalinomycin derivatives.
Li Y, Shi Q, Shao J, Yuan Y, Yang Z, Chen S, Zhou X, Wen S, Jiang ZX. Li Y, et al. Among authors: wen s. Eur J Med Chem. 2018 Mar 25;148:279-290. doi: 10.1016/j.ejmech.2018.02.004. Epub 2018 Feb 5. Eur J Med Chem. 2018. PMID: 29466777
Synergy between Auranofin and Celecoxib against Colon Cancer In Vitro and In Vivo through a Novel Redox-Mediated Mechanism.
Han Y, Chen P, Zhang Y, Lu W, Ding W, Luo Y, Wen S, Xu R, Liu P, Huang P. Han Y, et al. Among authors: wen s. Cancers (Basel). 2019 Jul 3;11(7):931. doi: 10.3390/cancers11070931. Cancers (Basel). 2019. PMID: 31277230 Free PMC article.
48 results
Jump to page